NYSEARCA:IDNA iShares Genomics Immunology and Healthcare ETF (IDNA) Price, Holdings, & News → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free IDNA Stock Alerts $24.18 -0.09 (-0.37%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$24.11▼$24.3050-Day Range$21.71▼$24.4252-Week Range$17.33▼$25.52Volume28,048 shsAverage Volume37,917 shsMarket Capitalization$141.45 millionAssets Under Management$141.52 millionDividend Yield0.58%Net Expense Ratio0.47% Stock AnalysisStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Get iShares Genomics Immunology and Healthcare ETF alerts: Email Address About iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.Read More IDNA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IDNA ETF News HeadlinesMay 18 at 7:17 PM | morningstar.comiDNA Genomics Public LtdApril 15, 2024 | finance.yahoo.comiShares Genomics Immunology and Healthcare ETF (IDNA)February 18, 2024 | seekingalpha.comIDNA: Healthcare Dashboard For FebruaryDecember 22, 2023 | msn.comiShares Genomics Immunology and Healthcare ETF declares semi-annual distribution of $0.1692December 16, 2023 | seekingalpha.comIBRN iShares Neuroscience and Healthcare ETFNovember 15, 2023 | lse.co.ukIshares Eur Corp Bond Ex-financials 1-5yr Ucits Etf Eur (acc) Share Price (IX5A.AM)November 13, 2023 | lse.co.ukIshares Uk Dividend Ucits Etf Dist Share Price (IUKD.MI)November 3, 2023 | investing.comIDNA ETF Stock Price HistorySee More Headlines Receive IDNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares Genomics Immunology and Healthcare ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IDNA Inception Date6/11/2019 Fund ManagerJennifer Hsui, Greg Savage, Paul Whitehead WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE FactSet Global Genomics and Immuno Biopharma Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings63 Fund Statistics Assets Under Management$141.52 million Average Daily Volume$0.00 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerJane Street Options OptionableOptionable Options Volume4 Put Options3 Call Options4 Short Interest500 shs Miscellaneous Outstanding Shares5,850,000Beta1.14 Creation Unit50,000 Creation Fee$850.00 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. iShares Genomics Immunology and Healthcare ETF ExpensesTypeIDNATheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.47%0.57%0.54%0.51%0.51%Other Expenses0.00%0.72%0.54%0.64%0.58%Total Expense0.47%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.76%-0.55%-0.68%-0.57%Net Expense0.47%0.59%0.60%0.58%0.58% iShares Genomics Immunology and Healthcare ETF (IDNA) Holdings & ExposureTop 10 IDNA HoldingsSarepta Therapeutics(NASDAQ:SRPT)Holding Weight: 5.72%Revolution Medicines(NASDAQ:RVMD)Holding Weight: 5.63%Moderna(NASDAQ:MRNA)Holding Weight: 5.38%Merck & Co., Inc.(NYSE:MRK)Holding Weight: 4.47%GLAXOSMITHKLINEHolding Weight: 4.33%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 4.23%SANOFI SAHolding Weight: 3.78%Exelixis(NASDAQ:EXEL)Holding Weight: 3.58%Incyte(NASDAQ:INCY)Holding Weight: 3.57%Iovance Biotherapeutics(NASDAQ:IOVA)Holding Weight: 3.40%IDNA Sector ExposureIDNA Industry ExposureFull Holdings Details Similar ETFsAvantis Responsible International Equity ETFNYSEARCA:AVSDHumankind US Stock ETFNYSEARCA:HKNDVanEck Low Carbon Energy ETFNYSEARCA:SMOGRoundhill Generative AI & Technology ETFNYSEARCA:CHATiShares MSCI Agriculture Producers ETFNYSEARCA:VEGI IDNA ETF - Frequently Asked Questions How have IDNA shares performed in 2024? iShares Genomics Immunology and Healthcare ETF's stock was trading at $23.01 at the beginning of 2024. Since then, IDNA stock has increased by 5.1% and is now trading at $24.18. View the best growth stocks for 2024 here. What does IDNA invest in? iShares Genomics Immunology and Healthcare ETF is a equity fund issued by iShares. IDNA focuses on theme investments and follows the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund's investments total to approximately $141.52 million assets under management. What stocks does iShares Genomics Immunology and Healthcare ETF hold? IDNA invests in 63 holdings. Some of the stocks in their portfolio include Sarepta Therapeutics (SRPT), Revolution Medicines (RVMD), Moderna (MRNA), Merck & Co., Inc. (MRK), Regeneron Pharmaceuticals (REGN), Exelixis (EXEL), Incyte (INCY), Iovance Biotherapeutics (IOVA), BioNTech (BNTX) and Gilead Sciences (GILD). What is the management fee for iShares Genomics Immunology and Healthcare ETF? iShares Genomics Immunology and Healthcare ETF's management fee is 0.47% and has no other recorded expenses or fee waivers. The net expense ratio for IDNA is 0.47%. What other stocks do shareholders of iShares Genomics Immunology and Healthcare ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Genomics Immunology and Healthcare ETF investors own include Pfizer (PFE), Gilead Sciences (GILD), Intel (INTC), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Novavax (NVAX), Canadian Natural Resources (CNQ), QUALCOMM (QCOM), SPDR S&P Biotech ETF (XBI) and Bristol-Myers Squibb (BMY). How do I buy shares of iShares Genomics Immunology and Healthcare ETF? Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:IDNA) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.